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Drosophila As a Model System for
Molecular Analysis of Tumorigenesis
by Bernard M. Mechler,* Dennis Strand,* Andreas Kalmes,*
Reinhard Merz,* Martina Schmidt,* and Istvan Torok*t
In Drosophila, homozygous mutations in a series of genes can cause the appearance of tissue-specific
tumors. These tumors occur either during embryonic or larval development. The majority ofthe identified
genes give rise to larval tumors that affect either the presumptive adult optic centers of the brain, the
imaginal discs, the hematopoietic organs, or the germ cells. These genes act as recessive determinants of
neoplasia and have been designated as tumor-suppressor genes. They are normally required for the reg-
ulation of cell proliferation and cell differentiation during development. Among these genes, the le-
thal(2)giant larvae (I(2)gl) has been best studied. Homozygous mutations in l(2)gl produce malignant
tumors in the brain hemispheres and the imaginal discs. The I(2)gl gene has been cloned, introduced back
into the genome of l(2)gl-deficient animals, and shown to restore normal development. The nucleotide
sequence of the l(2)gl gene has been determined, as well as the sequence of its transcripts. Anti-1(2)gl
antibodies recognize a protein ofabout 130 kDa that corresponds to the majorproduct of1(2)gl transcripts.
Analysis of the spatial distribution of 1(2)gl transcripts and proteins revealed a first phase of intensive
expression during embryogenesis and a second weaker phase during the larval to pupal transition period.
As revealed by mosaic experiments, the critical period of l(2)gl expression for preventing tumorigenesis
takes place during early embryogenesis. During this period, the 1(2)gl protein is ubiquitously expressed
in all cells and tissues, while during late embryogenesis expression becomes gradually restricted to the
midgut epithelium and the axon projections of the ventral nervous system that show no phenotypic al-
teration in the mutant animals. Biochemical studies revealed that the 1(2)gl protein can be metabolically
labeled with phosphate and is associated with the cytoplasmic face of the plasma membrane. Sequence
comparison hasfurthershownthatthe1(2)gl proteins containreiterated sequence motifsthat areconserved
in G proteins. These data present compelling evidence to implicate I(2)gl in a signal transduction process
that ultimately controls cell proliferation and differentiation.
Introduction
Genetic and molecular analyses of Drosophila have
clearlydemonstrated thattumorigenesis may arise from
inactivation of genes controlling cell growth and differ-
entiation (1,2). Recessive mutations in a series ofgenes
were shown to interrupt the differentation of defined
adult primordial cell types and lead to an uncontrolled
and invasive cell growth, resulting in the death of the
mutant animals before the completion of the normal
course of development.
In Drosophila, malignancies of genetic origin occur
either in the brain, the imaginal disc cells, or the he-
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matopoietic cells (3-5). With the exception of the le-
thal(2)giant larvae (1(2)gl) gene, whose inactivation re-
sultsinthe appearance oftumorsintwotypesoftissues,
brain and imaginal discs (1,6), all other mutations pro-
duce neoplasia in only one type oftissue (3-5). In gen-
eral, all the animals homozygously mutated at one gene
locus display a similar pattern of neoplasia. For ex-
ample, in the case of 1(2)gl, every single imaginal disc
becomes tumorous, and no variation can be observed
from animal to animal. This reproducible pattern oftu-
mors indicates that no secondary genetic event is re-
quired for eliciting full malignant transformation.
This is in contrast to tumor development in mammals
and particularly in humans, where this process appears
generally to be complex and results from accumulation
ofseveral genetic and epigenetic changes (7-9). Recent
studies on small cell lung cancer, breast cancer, and
colorectal cancer have shown that the full malignant
condition is associated with multiple genetic changes,
supportingthe concept ofamultigenetic etiology ofcan-
cer (11-14). However, certain childhood malignancies,MECHLER ET AL.
such as retinoblastoma, seem to originate from genetic
alterations of only a single gene (15-17).
Isolation ofthe putative retinoblastoma (Rb) gene has
confirmed that inactivation of Rb constitutes the pri-
mordial eventinthe malignant transformation ofhuman
retinal cells (18-21). In addition, inactivation ofthe Rb
gene has also been found to be common in other human
malignancies such as osteosarcomas, small-celllungcar-
cinomas, breast carcinomas, bladder carcinomas, and
cervical carcinomas (19,22,23). This indicates that the
Rb gene also plays a critical role in the control of neo-
plastic growth in these tissues, albeit not as cardinal as
inthe caseofretinalcells. Geneticand molecular studies
suggest strongly that further genetic alterations may
be required for the full transformation ofthese tissues.
The main candidates for involvement in these genetic
events are proto-oncogenes and tumor-suppressor
genes. Modifications in the structure and/or control of
these genes could induce the malignant phenotype.
Over the past decade, a series of dominantly acting
oncogenes has been detected through its ability to in-
duce cell proliferation and tumorigenesis. The onco-
genes are derived from deregulation or structural al-
terations of the products of proto-oncogenes that are
components ofthe normal cellulargenome. These genes
encode growth factors, growth factor receptors, signal
transducers, protein kinases, and transcription factors
whose activities are increased in their overexpressed or
mutated forms.
However, earlier genetic analysis of inherited child-
hood malignancies (15) and familial tumor syndromes
(24), as well as studies with somatic cells (25-27), have
revealed the existence of a countervailing class of ge-
netic elements whose normal activity is to control cell
proliferation. These genes have been designated reces-
sive oncogenes, anti-oncogenes, or tumor-suppressor
genes. Inactivation of these genes by deletion or point
mutations disrupts the checks and balances that regu-
late cell proliferation and development.
In Drosophila, both classes of cancer genes, tumor-
suppressor genes and proto-oncogenes, have been iden-
tified. On one hand, tumor-suppressor genes were first
found by virtue of loss of genetic function that results
in the appearance ofmalignancies in the homozygously
mutated animals (1,3-6). This finding led to the hy-
pothesisthat aclassofgeneticelements existsthatmust
be inactivated by deletion, point mutation, or translo-
cation before an animal can develop malignancies. Final
proof of this hypothesis was obtained when the 1(2)gl
gene was cloned, introduced back into the genome of
1(2)gl-deficient animals, and shown to restore normal
development (2,28,29).
On the the other hand, proto-oncogenes were de-
tected in the genome of Drosophila by molecular hy-
bridization at low stringencies with vertebrate onco-
genes. Other proto-oncogenes have been also identified
by finding Drosophila genes displaying similarity be-
tween the amino acid sequence of a cloned Drosophila
gene and the amino acid sequence of a vertebrate on-
cogene [for review, see Shilo (30) and Hoffman (31)].
While numerous Drosophila proto-oncogenes have been
identified, mutantalleles arecurrentlyavailableforonly
a subset of them. Although the studies of these muta-
tions have revealed that the Drosophila homologues to
vertebrate proto-oncogenes participate in essential pro-
cesses throughout the development, none ofthese mu-
tations was found to induce malignancies or develop-
mental abnormalities that would phenotypically re-
semble one ofthosethatcharacterize tumorprogression
in higher vertebrates, i.e., preneoplastic lesions like
hyperplasia.
However, hyperplasia resulting from genetic altera-
tions has also been recognized in Drosophila. Charac-
terization of a series of recessive lethal mutations has
revealed that five mutations, designated as epithelial
overgrowth mutants, can give rise to overproliferation
ofthe imaginal discs (33,34). Although these discs grow
to several times their normal size, they maintain a sin-
gle-layered epithelial organization and retain their ca-
pacity to differentiate.
In this report, we briefly review the current state of
information regarding tumorigenesis in Drosophila and
then focus on our current view of one of the members
ofthe tumor-suppressor genes thus far identified in in-
vertebrates: the lethal(2)giant larvae gene in Droso-
phila.
Drosophila Neoplasia
Thepossibilitythatmutations cancausetheformation
oftumors was envisaged by Drosophila investigators in
the early period of genetic endeavor at the beginning
of this century. The first mutation giving rise to a so-
called tumor (35) was found in the strain 1(1)17 by
Bridges in 1916; a lethal allele ofdeep-orange, dor (36).
However, the death of the dor'(1)i larvae was later
foundtobecausedbyamidgutmalformation (37). These
larvae form melanotic masses that morphologically re-
semble tumorsbutare devoid oftrulyneoplasticgrowth
(i.e., the hemocytes aggregate in melanizing nodules
and are unable to proliferate further). Upon the failure
of50 years ofgenetic analysis to obtain convincing data
showingthat insects can sufferfrom cancer, it was gen-
erally considered that insects were not able to produce
any neoplasm comparable to those occurring in verte-
brates (38). The occurrence of true neoplasms in Dro-
sophilamelanogasterwas only recognized afterthe iso-
lation and characterization of a new allele of the 1(2)gl
gene by Gateff and Schneiderman (1). Developmental
studies of 1(2)gl animals revealed that one ofthe man-
ifestations ofthe mutation was the formation ofmalig-
nantneuroblastomaandthe appearance ofimaginaldisc
tumors. Subsequently, other tumor mutations were
identified and shown to affect distinct types oftissues:
embryonic tissues, the optic centers ofthe larval brain,
the imaginal discs, the hematopoietic organs, and the
germ line cells. Altogether, 27 tumor genes have been
reported in the literature. Mutants in 17 of them cur-
rently exist in published stock lists (5) and are listed in
Table 1.
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Table 1. Neoplastic and hyperplastic mutants in Drosophila melanogaster.
Mutant Symbol Locus Map position
A. Neoplastic mutants
A. 1. Mutants producing embryonic
neoplasmsa
Df(l)Notch 1-3.0 3B4-E1
shibiretsl shit" 1-52.2
A.2. Mutants producing larval
neoplasmsb
A.2.1 Brain and imaginal
disc neoplasms
lethal(2)giant larvae 1(2)gl 2-0.0 21A
A.2.2. Brain neoplasms
lethal(2)37Cf 1(2)37Cf 2-53.9 37C5-7
lethal(3)malignant 1(3)mbt 3-93 97F
brain tumor
A.2.3. Imaginal disc neoplasms
lethal(l)discs-large 1 1(1)d.Ig-1 1-34.8 1OB8-9
lethal(2)tumorous discs 1(2)tud 2-104 59F5-8
A.2.4 Blood cell neoplasms
lethal(l)malignant blood 1(1)mbn 1-27.6 8D
neoplasm
Tumorous lethal Tum 1-34.5
lethal(3)malignant blood 1(3)mbn-1 3-13.3 64F3-65A3
neoplasm-1
lethal(3)malignant blood 1(3)mbn-2 3.
neoplasm-2
A.3. Germ line neoplasmsc
female sterile(1)231 fs(1)231 1-
female sterile(1)1621 fs(1)1621 1-11.7
fused fu 1-59.5
female sterile(2) of Bridges fs(2)B 2-5
narrow nw 2-83
benign(2)gonial cell b(2)cgn 2-106.7 60A3-7
neoplasm
B. Hyperplastic mutantsd
lethal(2)fat 1(2)ft 2-12 24D8
lethal(2)giant discs 1(2)gd 2-42.7 32AE
lethal(3)c43 1(3)c43 3-49.0 85E
lethal(3)disc overgrowth-2 1(3)dco-2 3-70.7
lethal(3)disc overgrowth-1 1(3)dco-1 3- 10OA1.2-Bl
'The mutants develop abnormalities during embryonic development and die during embryogenesis. Neoplastic potential of the embryonic
tissues is assayed by transplanting them into the abdomen of adult flies in which the neoplastic cells proliferate rapidly, form tumors, and kill
the host.
bThe mutants develop neoplasia during larval development and die as third-instar larvae, pseudopupae, or pupae.
cThe mutants develop benign tumors that remain confined to the gonads and that lead only to sterility without otherwise impairing the
development of the mutant animals.
dThe mutants develop overgrown imaginal discs during larval development and die as third-instar larvae, pseudopupae, or pupae.
Growth Potentialities during
Drosophila Development
Before committing to neoplastic growth, a cell must
be able to duplicate all its essential parts. This ability
is normally limited to undifferentiated cells that are
either in a proliferative phase or quiescient but readily
recruitable into mitosis. During Drosophila develop-
ment, two major proliferative phases take place. First,
a relatively short but intense phase ofcell proliferation
occurs duringthe first 3hrofDrosophila embryogenesis
and, after 16 rounds of mitosis, leads to the formation
of two classes of embryonic cells: those that will form
the larval tissues and will grow mainly by expansion of
cell volume with continued rounds of DNA replication
without cytokinesis and resulting in chromosome po-
lytenization, and those that will constitute the anlagen
ofthe adult organs. These latter cells remain quiescent
andundifferentiated duringtheremainingperiod ofem-
bryonic development. During larval life, they resume
proliferation from the middle of the first larval instar
and divide throughout the three larval stages up to the
larval-pupal transition, arresting only as terminal dif-
ferentiation occurs.
Therefore, cell overproliferation can only be noticed
at the end of both major proliferative phases, and, ac-
cordingly, mutations producing neoplasia have been
identified at the end of either one or the other period.
Phenotypic Characteristics of
Drosophila Neoplasia
Embryonic neoplasia does not form visible tumors.
Therefore, an assay is required for recognizing neopla-
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siain embryos. For this purpose, fragments ofputative
neoplastic tissues are implanted into the abdomen of
adult flies. Under these conditions, the neoplastic cells
proliferate rapidly, invade the abdominal cavity, and
kill the host in3 to 14 days (1,6,34). Bycontrast, normal
tissues grow moderately and exert no deleterious effect
onthe host. This procedure provides an efficient system
for distinguishing between normal and neoplastic tis-
sues. Through this assay, two mutations giving rise to
embryonicneoplasia, Df(1)Notchandshibire, havebeen
identified (6).
Larval neoplasia produces massive outgrowths oftu-
morous tissues that become clearly visible during the
several-day extension oflarval life. During this period,
the tumorous tissues may reach several timestheirnor-
mal size, and the mutant larvae become either bloated
(or "giant") and transparent when they have brain or
imaginal disc tumors orwhite opaque orcompletely me-
lanized when they are affected by blood neoplasia. In
the transplantation assay, brain, imaginal disc, and
blood neoplasiaproliferaterapidlyand, infewdays, lead
to the death ofthe host (34).
Cell overproliferation affecting the germ line is es-
sentially detected in the adult organism in which it
causes sterility. Overgrowth remains confined within
the gonads and does not otherwise impair the devel-
opment ofthe fly. Similarly, when transplanted into an
adult host, these cells remain confined within the trans-
plantedgonads and areunable to sustain an autonomous
growth. Mutations giving rise to germ line overproli-
feration affect essentially the female germ line, with the
exception of the b(2)gcn mutation that gives rise to
overproliferation ofbothmaleandfemale germline (39).
These mutations are currently considered as affecting
the sex determination ofthe germ line ratherthan caus-
ing true neoplasms.
Similarly, overgrowth ofthe imaginal discs produced
by the epithelial overgrowth mutations does not show
characteristics of malignant neoplasms. These over-
grown discs maintain a single-layered epithelial struc-
ture, with normal apical-basal cell polarity, and con-
serve their ability to differentiate, albeit forming ab-
normal cuticular structures.
In general, Drosophila neoplasms display a range of
characteristics similar to those defining neoplasms of
vertebrates. The main characteristics are thefollowing:
a) in situ cell overproliferation, b) altered cell mor-
phology, c) loss of differentiation capacity, d) in situ
invasiveness, and e) transplantability. However, these
features characterize essentially the mostmalignant tu-
mors, and, as in vertebrate neoplasms, Drosophila tu-
mors may-display only some of these properties. In
particular, the 1(3)mbn hemocytes proliferate and in-
vade all larval tissues but do not proliferate in adult
hosts (40).
Finally, in addition to the appearance of malignant
neoplasms, these mutations may exert deleterious ef-
fects on other tissues. Inparticular, the 1(2)gl mutation
affects the development ofnumerous tissues (i.e., atro-
phy of the male germ line, underdevelopment of the
imaginal cells ofthe salivary glands and the gut) before
the appearance of the overgrown neoplasms (41,42).
Therefore, these mutations produce pleiotropic effects,
neoplasia being the most striking feature.
Genetic analysis of Drosophila strongly supports the
concept that cell proliferation and cell differentiation
may be negatively regulated. The importance of the
genes involved in these processes has quite recently
come to the forefront. The techniques of molecular bi-
ology used for the analysis of oncogenes have already
greatly increased our understanding of the processes
required to control normal and defective proliferation.
However, genetic analysis of proto-oncogenes has
clearly shown that, in Drosophila, these genes cannot
be causally related with tumor development. From the
molecularisolation oftumor-suppressor genes and their
analysis, we can expect numerous exciting discoveries.
These findings will help to dissect and identify signifi-
cantregulatory components ofcellproliferationandmay
offergreathopeforfurtherinsightsintothebasicmech-
anisms leading to tumorigenesis.
The 1(2)gI Gene
The lethal(2)giant larvae gene was the first molecu-
larly isolated tumor-suppressor gene (2). Furthermore,
integrationofanormalcopyofthisgeneintothegenome
of 1(2)gl-deficient animals was shown to restore normal
development and consequently prevent tumorigenicity.
Homozygous mutations in the 1(2)gl gene lead to ma-
lignant transformation ofthe neuroblasts and ganglion
mother cells of the adult optic centers in larval brain
and of the imaginal disc cells (1,6). Among Drosophila
cancer genes, the mutations in the 1(2)gl gene are the
only mutations giving rise to simultaneous appearance
of malignancies in two distinct tissues. In homozygous
1(2)gl-deficient animals, these neoplasms first become
visible in the third larval instar. The brain hemispheres
and the imaginal discs grow to several times their nor-
mal size during the extended life of the 1(2)gl larvae.
Presumably, the invasive growth ofthe malignant neu-
roblastswithinthebrainhemispheres disruptsessential
functions for the maturation of the ring gland and its
ecdysone-producing cells (43,44). As aconsequence, the
ring gland remains underdeveloped and, because ofthe
lack of ecdysone, puparation is considerably delayed.
However, the atrophy of the ring gland is apparently
not the primary defect in the mutant animals because
neither the transplantation of a normal ring gland into
1(2)gl-deficient larvae (45) nor the injection ofecdysone
(46)fullyrescuethe developmentofthemutantanimals.
Furthermore, ecdysone alone is not sufficient to cause
neoplastic growth (47,48). Other tissues like the fat
bodies become involuted, but their atrophy seems to be
caused by the development arrest resulting from the
occurrence of malignancies and may not be related to
the absence of 1(2)gl gene expression in these tissues.
By contrast, the underdevelopment oftissues, such as
the gonads and the imaginal cells ofsalivary glands and
the gut, occurs before the outgrowth ofthe tumors and
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can be directly attributed to the absence of 1(2)gl gene
activity in these tissues (42). For example, in 1(2)gl-
deficient animals, the development of the male germ
line is arrested during early larval life, whereas the
development of the female germ line proceeds further
(49).
The most striking characteristic of the 1(2)gl pheno-
type is certainly the neoplastic growth affecting the
optic centers ofthe larval brain and the imaginal discs.
When fragments of both of the overgrown tissues are
transplanted into the abdomen of adult wild-type flies,
the tissues behave as malignant tumors. They grow
autonomously and kill the host fly within 1 to 2 weeks
(1,6).
The first 1(2)gl mutant was discovered by Bridges in
1933 (50) and has been mapped to position 21A-B at the
extreme left end of the second chromosome (51).
Molecular Identification of the 1(2)gl Gene
Insituhybridization topolytenechromosomes ofgen-
omic DNA sequences expressing pole-cell-specific tran-
scripts revealed that one of the isolated sequences de-
rived from the 21A region (2) where the 1(2)gl was
previously located (51). Assignment of this DNA seg-
ment to the 1(2)gl locus was further reinforced by ana-
lyzing polytene chromosomes heterozygous for 1(2gl
mutations. This analysis showed that the cloned DNA
segment was deleted in 1(2)gll and 1(2)gl4, two inde-
pendently isolated 1(2)gl mutant alleles (2). Subsequent
analysis of more than 50 spontaneously occuring and
ethyl methane sulfonate-induced 1(2)gl mutations by
Southern genomic blotting confirmed that almost all
1(2)gl mutations consisted of relatively large deletions
in which part or all of the DNA sequence between the
telomere and the cloned region was absent. However,
two mutants, 1(2)glGB52and1(2)glDV275, displayed struc-
tural alterations within the cloned region. The 1(2)
glDV27Smutationexhibits aninterstitial deletionofabout
9 kb, whereas the 1(2)glGBS2 is characterized by the
insertion of a 10 kb DNA which was later identified as
amobileelementofthe B104family(52). Finally, North-
ern blot analysis has led to the delimitation of a tran-
scription unit which is altered in all examined 1(2)gl
mutant alleles. The putative 1(2)gl transcription unit
encompasses a 13.1 kb segment of DNA that in sub-
sequent studies was shown to contain all the necessary
sequences for correct expression.
1(2)gl Gene Transfer and Gene Rescue
In Drosophila, functional activity ofa cloned gene can
be tested by generating transgenic flies through intro-
duction by P-element-mediated gene transfer (53,54).
In the case of1(2)gl, the 13.1 kb EcoRI DNA fragment
covering the putative 1(2)gl transcription unit was in-
corporated into a P-element transposon (28). This con-
struct was microinjected into embryos of Drosophila
heterozygous for 1(2)gl. Transgenic animals were se-
lected and backerossed so that isogenic lines could be
obtained. From the segregation ofthe progeny, it was
clear that the cloned sequence was able to fully rescue
the development of 1(2)gl-deficient animals that other-
wise would have died ofbrain and imaginal disc tumors.
These results demonstrate that all the necessary se-
quences for in vivo function of the 1(2)gl gene are in-
cluded within the 13.1 kb DNA fragment and show that
the development of brain and imaginal disc tumors re-
sults from the absence of1(2)gl function (28). When this
function is restored, tumorigenesis is completely sup-
pressed.
Structure of the 1(2)gl Gene and Its
Transcripts
The entire 13.1 kb DNA segment encoding the 1(2)gl
sequence, as well as several cDNAs, has been se-
quenced (29). This analysis was revealed that the 1(2)gl
gene can be divided in roughly two equal moieties. The
proximal moiety is made of two direct repeats, each
about 2.8 kb in size. These repeats show a high degree
(96%) of homology. Sequence analysis of a series of
cDNAs, S1 mapping, and primerextensionexperiments
have shown that initiation oftranscription can occur in
both repeats, at about 0.4 kb upstream from their prox-
imal limits (55; M. Schmidt, I. Torok, and B. Mechler,
in preparation). Depending on the splicing pattern, this
duplication leads to the synthesis of transcripts that
differ in their 5' region. However, these variations af-
fect only the 5' untranslated region and therefore bear
no consequence on the 1(2)gl protein structure. More-
over, as shown by gene transfer experiments, the pro-
moter present in each repeat can fully direct the 1(2)gl
gene expression. Further analysis of homologous se-
quences to 1(2)gl in related Drosophila species, such as
D. simulans, D. mauritiana, D. erecta, andD. yakuba,
indicated that the duplication ofthe proximal moiety of
the gene is likely to be a relatively recent event (be-
tween 1 and 2 million years ago) since it is only found
in D. melanogaster and is absent in all other investi-
gated Drosophila species (P. Mendes and B. Mechler,
unpublished observation).
The distal moiety of the 1(2)gl gene contains almost
allthe coding sequence ofthe gene. Sequence alignment
ofthe longest isolated cDNA, Ecl73, revealed that this
cDNA extends over 10 exons (29). The first three exons
derive fromthe duplicated 5' region, whereas the seven
other exons containing almost all the coding region of
the gene originate from the unique 3' region. Sequence
analysis of this cDNA indicated that the longest open
reading frame encodes a protein of 1161 amino acids in
length with a relative mass of 126.9 kDa: designated as
p127 protein. From sequence divergence found in an-
other cDNA, Ec371, a second 1(2)gl protein can be pre-
dicted with a length of 708 amino acids and a relative
mass of 78.1 kDa, designated as p78 protein (29).
The divergence found in the coding sequence was as-
sumed to represent the two size classes of 1(2)gl tran-
scripts that were previously observed in Northern blot
analysis (2). However, results from several lines of in-
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vestigation, such as structural analysis of the tran-
scripts, gene dissection and reconstitution studied in
transgenic flies, and protein analysis, suggested that
the 4.5-kb transcripts may correspond to cleaved prod-
ucts of the 6 kb transcripts. This cleavage may repre-
sent a degradation process affectingthe 3' untranslated
portion of the 1(2)gl transcripts that contain numerous
AUUUA repeats to confer mRNA lability (56; M.
Schmidt, I. Torok, and B. Mechler, in preparation).
Structure of the 1(2)gl Polypeptide
From structural and sequence analyses of the 1(2)gl
transcripts, it appears that the 1(2)gl gene encodes es-
sentially a polypeptide of about 127 kDa in size. using
rabbit antiseraprepared against a ,B-galactosidase-1(2)gl
fusion protein, amajorprotein ofan apparentmolecular
mass ofabout 130,000 can be identified on Western blot
or can be immunoprecipitated.
Sequence comparison of the putative 1(2)gl protein
with protein sequences in the general data bases has
not shown any significant homology with any of the
proteins compiled. Examination ofthe sequence did not
reveal any obvious pattern thatwould indicate aspecific
function (e.g., zinc finger, leucine zipper, or other) or a
specific subcellular localization (e.g., NH2-terminal hy-
drophobic signal secretion sequence, potential hydro-
phobic transmembrane domain, karyophilic domain, or
other) of the 1(2)gl sequence. On the basis ofthe pres-
enceofanArg-Gly-Asp (RGD) sequence, characterizing
cell adhesion molecules and the arrangement of Cys
residues, it has been suggested that the 1(2)gl protein
ishomologous toneuralcelladhesion molecule (N-CAM)
(57). However, detailed examination ofthe1(2)glprotein
sequence did not show any relationship to the immu-
noglobulin supergene family to which N-CAM belongs
(58). Moreover, we have found that the RGD sequence
is absent in the putative homologous protein sequence
of other insects such as Calliphora erythrocephala (59;
I. Torok and B. Mechler, in preparation). A further
report, published by the same group of investigators,
consider that the 1(2)gl protein may be homologous to
a cadherin cell adhesion molecule because the 1(2)gl pro-
tein appears to be localized at the surface ofembryonic
cells (60). However, this contention is not substantiated
when these described similarities are compared with
corresponding domains of homologous sequences to
1(2)gl identified in other insects (I. Torok and B. Mech-
ler, in preparation).
Cellular Localization of the 1(2)gl Protein
Immunostaining of sections of Drosophila embryos
has revealed that the 1(2)gl protein is localized at the
cell periphery (55,57). Because no N-terminal secretion
signal sequence or transmembrane domain could be
identified in the 1(2)gl protein, we have investigated the
association of the 1(2)gl protein with with the plasma
membrane. Using cell fractionation procedures, we
were able to show that the 1(2)gl protein is tightly as-
sociated withmembrane and cannot be released byhigh
saltwashes orEDTAtreatment(D. Strand, A. Kalmes,
R. Merz, and B. Mechler, in preparation). The orien-
tation ofthe 1(2)gl protein with regard to plasma mem-
brane was further studied by treating intact embryonic
cells or cell extracts with proteases, such as trypsin.
These experiments showed that the 1(2)gl protein was
fully protected against proteolysis when the cells were
intact but was degraded when the cells were lysed with
detergents (D. Strand et al., in preparation). On the
basisoftheseresults, we concludethatthe 1(2)glprotein
is bound to the inner surface ofthe plasma membrane.
The exact nature of this binding is not yet known but
may result from either posttranslational modification of
the 1(2)gl protein or interaction with other proteins.
Function of the 1(2)gl Protein
The analysis of the amino acid sequence of the pu-
tative 1(2)gl protein did notprovide anydirectindication
of its function, and several attempts for identifying
structural homologies with protein sequences in data
bases were equallyunsuccessful untilwe gotindications
thatthe 1(2)gl proteinwas associated withtheinnerface
of the plasma membrane and can be metabolically la-
beled with [32P]phosphate. On this basis we searched
forconservedmotifs amongproteins exhibitingasimilar
intracellular localization. This comparison revealed the
presence ofthree reiterated motifs in the centralregion
ofthe 1(2)gl protein that show similarities with repeats
characterizing 1-subunits of G-proteins (61) and dis-
playing the consensus sequence:
LxxGHxxx(I/V)xx(I/LNV)xxxxx
(G/S)xx(I/L/V)x(S/T)xDxx(I/L/V)WD
Fivesuchrepeatswitha42to64aminoacidunitinterval
are usually present in the ,B-subunits of G proteins
whereas, in 1(2)gl, we have only identified three repeats
that are reiterated with an 86 to 89 amino acid interval.
The function of the repeat structure is unknown, but,
due to its presence in protein unrelated to G protein
such as the yeast PRP4 protein that is involved in the
process of RNA splicing, it has been speculated that
the complex motif may play a role in protein-protein
interaction (61).
In conjunction with the finding that the p127 protein
binds to the inner face of the plasma membrane, the
presence ofthese motifs suggests thatthe 1(2)gl protein
may establish contact with other proteins and through
these interactions may play a role in a signal pathway
that ultimately controls cell proliferation and cell dif-
ferentiation.
Spatio-Temporal Expression Patterns of
1(2)gl and Critical Period for
Establishment of Neoplasia
Northern blot analysis has revealed that the 1(2)gl
gene is essentially active during embryogenesis and
during the larval-pupal transition phase. Interestingly,
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these two phases of 1(2)gl gene expression correspond
to the two major periods of cell proliferation during
Drosophila development. It is therefore important to
determine the respective contribution ofeach period of
1(2)gl expression in relationship with tumorigenicity.
Atfirst, the appearance oftumors that become visible
during the extended larval life ofthe 1(2)gl mutant an-
imals would suggest that the control of tumorigenesis
takes place duringthe second period ofgene expression.
Such a hypothesis would also implicate that 1(2)gl acts
as a direct repressor ofcell proliferation. However, this
hypothesis is contradicted by two observations. First,
the 1(2)gl-deficient embryos are able to complete their
embryogenesis normally with no apparent morpholog-
ical alteration. Second, transplantation of1(2)gl embry-
onic cells into the abdomen of adult hosts has revealed
that these cells produce tumors and are therefore com-
mitted to neoplastic growth.
In order to determine more precisely the critical
phase for the establishment of neoplasia during Dro-
sophila development, we have examined the tumori-
genicity ofclones of1(2)gl-deficient cells that have been
induced at different developmental periods. Analysis of
1(2)gl mosaic animals indicated clearly that neoplastic
growth can only take place in clones of cells that have
lostthe 1(2)glgeneinpreblastoderm syncyticalembryos
prior to any expression ofthe 1(2)gl gene. By contrast,
1(2)gl clonesthatareproduced atlaterembryonic stages
do not exhibit a neoplastic phenotype but are unable to
complete differentiation. Finally, 1(2)gl clones arising
during larval development show a nearly normal ornor-
mal differentiation. These data indicate strongly that
the critical period for the establishment of 1(2)gl neo-
plasia occurs during embryogenesis (55).
Analysis of the embryonic expression of 1(2)gl as re-
vealed by in situ hybridization and immunostaining
showed that 1(2)gl is ubiquitously expressed in all cells
during early embryogenesis from the cellular blasto-
derm stage up tothe germband extension stages (about
8.5 hr of embryonic development). During this period,
1(2)gl expression remainsuniformandrelativelyintense
over all embryonic cells (55,58). At the time for the
dorsal closure (about 110 hr ofdevelopment), the 1(2)gl
transcripts become graduallyrestricted tothe epithelial
cells of the midgut where they persist until the end of
embryogenesis anddisappearinallothertissues(55,58).
Immunostaining analysis revealed that the pattern of
1(2)gl protein expression follows generally the pattern
of1(2)gl transcription. In early embryos, the 1(2)gl pro-
tein is evenly distributed in all embryonic cells. In late
embryos, theproteinis onlydetected inthemidgutcells
and in central nervous system. The accumulation ofthe
1(2)glprotein in the axons indicate thatthe 1(2)gl protein
turnover and/or translational efficiency of the 1(2)gl
transcripts intheneuroblasts maybedifferentfromthat
in other tissues.
Thus, 1(2)gl displays a complex pattern ofexpression
that is not only limited to regions of embryonic map
predicted to be the domain of 1(2)gl activity. 1(2)gl is
first ubiquitously expressed during early embryogene-
sis and then becomes limited to domains that do not
exhibit any apparent pattern of damage in the absence
of 1(2)gl.
With respect to tumorigenesis, it is only during early
embryogenesis that a correlation can be established be-
tween 1(2)gl expression and the tumor phenotype. At
this time 1(2)gl is expressed in the epidermal and neural
precursors, the progeny of which are tumorigenic in
1(2)gl-deficient animals. This correlation is further
strengthened by the results ofthe mosaic analysis that
showed that the early embryonic expression of1(2)gl is
necessary for preventing tumorigenesis. Furthermore,
this period of gene expression seems to be also impor-
tant for the other tissues that exhibit nontumorigenic
phenotypic alterations.
The information that we have gained from the mo-
lecular analysis of the 1(2)gl gene leaves a number of
unresolved questions and paradoxes. Although 1(2)gl is
expressed in a wide variety of tissues, its inactivation
affects only a limited number of tissues, whereas most
ofthetissues areunaffected. Reducedgrowthcapacities
are observed in some cell lineages, such as the germ
line, the imaginal cells of the salivary glands, and the
prothoracic cells of the ring gland, whereas neoplastic
growth occurs only in the imaginal disc cells and the
neuroblasts and ganglion mother cells of the presump-
tive adult optic centers in the larval brain.
Equally perplexing is the delayed appearance of the
tumors. The malignant pattern ofgrowth only becomes
visible during late larval life, although it can be directly
correlated with the absence of 1(2)gl gene expression
during early embryogenesis. Also intriguing is the ab-
sence ofdirect visible effect ofthe lack of1(2)gl expres-
sion onthe embryonic development that appears to pro-
ceed normally. In particular, no overgrowth of any
tissue can be observed, indicating that the potential
tumorigenic cells first follow a normal pattern of de-
velopment with cessation of cell division during late
embryogenesis similar to that in wild-type embryos.
How the 1(2)gl gene product controls cell growth and
cell differentiation clearly depends on the cellular con-
text in which 1(2)gl is expressed. It is possible to con-
ceive that the 1(2)gl protein plays a broad role in linking
plasma membrane-bound receptors to intracellular ef-
fector proteins. These components may vary depending
on the cell type. Therefore, it will be important to de-
termine the nature of these components and to define
their contribution in the establishment of tumorigene-
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